ES
Enavate Sciences Portfolio holdings
AUM
$507M
1-Year Est. Return
181.76%
1 Year Est. Return
+181.76%
AUM
$507M
AUM Growth
+$179M
(+55%)
Holding
7
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZBIO
1
Zenas BioPharma
ZBIO
$1.26B
| $142M | 28.08% |
3,919,159
+157,800
|
|
||
2
Immunome
IMNM
$2.34B
| $102M | 20.21% |
4,768,583
|
|
||
|
SION
3
Sionna Therapeutics
SION
$1.61B
| $102M | 20.12% |
2,478,030
|
|
||
|
UPB
4
Upstream Bio Inc
UPB
$525M
| $66.8M | 13.18% |
2,459,703
|
|
||
5
Compass Therapeutics
CMPX
$969M
| $41.8M | 8.25% |
7,788,150
|
|
||
|
BBOT
6
BridgeBio Oncology
BBOT
$759M
| $32.9M | 6.49% |
2,626,946
|
|
||
7
CAMP4 Therapeutics
CAMP
$288M
| $18.6M | 3.67% |
3,035,825
-749,977
|
|